BlueRipple Health

Multivariable Mendelian Randomization Prioritizes ApoB as Key Lipid Risk Factor for Coronary Artery Disease

Verena Zuber, Dipender Gill, Mika Ala-Korpela · Mendelian randomization study

BlueRipple Assessment

Evidence Strength 88/100 · Strong
Clinical Significance 92/100 · Strong

The original source

Zuber V, Gill D, Ala-Korpela M, et al. High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease. Int J Epidemiol. 2021;50(3):893–901.

Sample size: 453,595
View original →
ApoBLDL-CTriglyceridesMendelian RandomizationCoronary Artery DiseaseCausal Lipid Risk

← All journal research

BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.